Your browser does not support SVG.
January 2, 2019
Dermavant Sciences Announces Appointment of Dr. Ph ...
Dermavant Sciences to Present Data on Tapinarof for Psoriasis and Atopic Dermatitis at the 2019 American Academy of Dermatology Annual Meeting
Dermavant Sciences Announces Appointment of Dr. Philip M. Brown as Chief Medical Officer
Dermavant Sciences to Present New Data on Cerdulatinib for Atopic Dermatitis and Vitiligo at the 3rd Annual Inflammatory Skin Disease Summit
Dermavant Appoints Todd Zavodnick as Chief Executive Officer
Dermavant Sciences to Present Tapinarof Phase 2B Data on Patient-Reported Outcomes for Psoriasis and Atopic Dermatitis at the Fall Clinical Dermatology Conference